These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 27419382)

  • 41. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
    Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
    Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
    Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
    Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study.
    Hoffman JP; Lipsitz S; Pisansky T; Weese JL; Solin L; Benson AB
    J Clin Oncol; 1998 Jan; 16(1):317-23. PubMed ID: 9440759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
    Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
    Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
    World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma.
    Nussbaum DP; Adam MA; Youngwirth LM; Ganapathi AM; Roman SA; Tyler DS; Sosa JA; Blazer DG
    Ann Surg Oncol; 2016 Mar; 23(3):1026-33. PubMed ID: 26542590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The natural history of resected pancreatic cancer without adjuvant chemotherapy.
    Hernandez JM; Morton CA; Al-Saadi S; Villadolid D; Cooper J; Bowers C; Rosemurgy AS
    Am Surg; 2010 May; 76(5):480-5. PubMed ID: 20506876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T; Hamada C; Baba H
    World J Surg; 2006 Feb; 30(2):213-8. PubMed ID: 16425074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer.
    Biankin AV; Kench JG; Colvin EK; Segara D; Scarlett CJ; Nguyen NQ; Chang DK; Morey AL; Lee CS; Pinese M; Kuo SC; Susanto JM; Cosman PH; Lindeman GJ; Visvader JE; Nguyen TV; Merrett ND; Warusavitarne J; Musgrove EA; Henshall SM; Sutherland RL;
    Gastroenterology; 2009 Aug; 137(2):558-68, 568.e1-11. PubMed ID: 19376121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Gastrectomy with either wedge resection of the pancreas or pancreaticosplenectomy for adenocarcinoma of the esophagogastric junction invading the pancreas: a comparison study].
    Liu JF; Liu XB; Wang Z; Shi ZH; Cao BJ; Jiang T; Zhang SW
    Zhonghua Wai Ke Za Zhi; 2019 Jun; 57(6):452-456. PubMed ID: 31142071
    [No Abstract]   [Full Text] [Related]  

  • 52. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades.
    Winter JM; Brennan MF; Tang LH; D'Angelica MI; Dematteo RP; Fong Y; Klimstra DS; Jarnagin WR; Allen PJ
    Ann Surg Oncol; 2012 Jan; 19(1):169-75. PubMed ID: 21761104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neoadjuvant therapy versus upfront surgery for early-stage left-sided pancreatic adenocarcinoma: A propensity-matched analysis from a national cohort of distal pancreatectomies.
    Nassour I; Adam MA; Kowalsky S; Al Masri S; Bahary N; Singhi AD; Lee K; Zureikat A; Paniccia A
    J Surg Oncol; 2021 Jan; 123(1):245-251. PubMed ID: 33103242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Has survival improved following resection for pancreatic adenocarcinoma?
    Luberice K; Downs D; Sadowitz B; Ross S; Rosemurgy A
    Am J Surg; 2017 Aug; 214(2):341-346. PubMed ID: 28601189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study.
    de Geus SWL; Kasumova GG; Eskander MF; Ng SC; Kent TS; James Moser A; Vahrmeijer AL; Callery MP; Tseng JF
    J Gastrointest Surg; 2018 Feb; 22(2):214-225. PubMed ID: 29235000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma.
    Abbott DE; Tzeng CW; Merkow RP; Cantor SB; Chang GJ; Katz MH; Bentrem DJ; Bilimoria KY; Crane CH; Varadhachary GR; Abbruzzese JL; Wolff RA; Lee JE; Evans DB; Fleming JB
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S500-8. PubMed ID: 23397153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The detail of the en bloc technique and prognosis of spleen-preserving laparoscopic distal pancreatectomy for pancreatic cancer.
    Sun Z; Zhu Y; Zhang N
    World J Surg Oncol; 2015 Nov; 13():322. PubMed ID: 26607990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium.
    Groen JV; Sibinga Mulder BG; van Eycken E; Valerianova Z; Borras JM; van der Geest LGM; Capretti G; Schlesinger-Raab A; Primic-Zakelj M; Ryzhov A; van de Velde CJH; Bonsing BA; Bastiaannet E; Mieog JSD
    Ann Surg Oncol; 2018 Nov; 25(12):3492-3501. PubMed ID: 30151560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.
    Torgeson A; Lloyd S; Boothe D; Tao R; Whisenant J; Garrido-Laguna I; Cannon GM
    Cancer; 2017 Oct; 123(19):3816-3824. PubMed ID: 28621885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Patient Age on the Postoperative Survival in Pancreatic Head Cancer.
    Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Ann Surg Oncol; 2017 Oct; 24(11):3220-3228. PubMed ID: 28695390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.